Cipla Health Care Pharmaceuticals Limited Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Industry

Employee Data

  • Cipla Health Care Pharmaceuticals Limited has 18 Employees.(i)
  • Cipla Health Care Pharmaceuticals Limited grew their employee count by 13% last year.

Cipla Health Care Pharmaceuticals Limited's People

NameTitleEmail/Phone
1
CEO Cipla Digital HealthReveal Email/Phone
2
VPReveal Email/Phone
3
Commerical Head | VPReveal Email/Phone
4
CEOReveal Email/Phone
5
Sr. VP, Quality Operations (Goa, USA and SAGA)Reveal Email/Phone
6
QA Officer in Cipla Ltd. GoaReveal Email/Phone
7
Head - FP&A and Controller in EM&EU FinanceReveal Email/Phone
8
Production OfficerReveal Email/Phone
9
Production OfficerReveal Email/Phone
10
Security OfficerReveal Email/Phone

What Is Cipla Health Care Pharmaceuticals Limited?

Cipla Health Care Pharmaceuticals Limited is a biotechnology company based out of Cipla House Peninsula Business Park Ganpatrao Kadam Marg, Mumbai, Maharastra, India.

keywords:N/A

N/A

Total Funding

18

Number of Employees

N/A

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cipla Health Care Pharmaceuticals Limited News

2022-04-20 - Myotonia Congenita Treatment Market By Emerging Trends ...

... Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., ... congenita treatment market is the rising healthcare expenditure.

2022-04-19 - Severe Acute Respiratory Syndrome (SARS) Treatment ...

... labs Ltd., Cipla Ltd., Cadila healthcare Ltd., Ipca laboratories ... Due to the high number of drug approvals for the treatment of...

2022-04-19 - Global Hepatitis B Therapeutics Markets, 2022-2026: A Strong Pipeline and Increasing Awareness and Screening Programs of HBV Diagnostic Tests will Lead to Sizable Demand - ResearchAndMarkets.com

Also, a strong pipeline, and increasing awareness and screening ... Bristol Myers Squibb Co., CASI Pharmaceuticals Inc., Cipla Ltd.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M18N/AN/A
#2
$1.6M18N/AN/A
#3
$0.8M18N/AN/A
#4
N/A18-5%N/A
#5
N/A1820%N/A